Jadavpur University hosts IAPST International Conference
Posted on Jan 17 2014 | IBNS
Kolkata, Jan 17 : The Department of Pharmaceutical Technology, Jadavpur University along with the NSHM Knowledge Campus Group of Institutions and Indian Association of Pharmaceutical Scientists and Technologists (IAPST) on Friday hosted the 2nd Pharma Tech IAPST International Conference, here.
The three-day conference from Jan 17 to 19 on the topic 'New Insights into Diseases and Recent Therapeutic Approaches', will be attended by more than a thousand delegates from across the world and India, including some of the leading scientists, researchers and doctors from Germany, UK, USA, Sweden, Hungary, Singapore and other countries.
According to the officials, many of the existing diseases have no curative treatments and lots of investigations are on to arrive at a curative destination.
Such diseases are popularly known as the ABCD diseases - A stands for AIDS; B stands for Brain and neurological disorders; C stands for cancer; D stands for diabetes, similarly, their therapy is equally important, the officials noted.
Prof Subhasis Maity, Jt Organisational Secretary Pharma Tech, Controller of Examinations, WBUT and Director of NSHM Knowledge Campus Group of Institutions said, "We look forward to more insights into ABCD diseases and their therapeutic combats with our colleagues from around the world."
Maity said, "In a very recent development, a group of physicians in a hospital in Kolkata has successfully developed a method of painless delivery. In last December a group of scientists from Kolkata has developed an important protein, which can be useful to detect the ovarian cancer much early and probably the protein expression, if inhibited, may be useful to control the progress of the disease."
"Although, we agree that cell signaling study in a micro-environmental system, sometimes does not mimic in vivo," he added.
"This is the time to discuss on those issues so that in near future we can give a better picture about the cause of such diseases and provide much better therapeutic approaches, including drug targeting and tailored medicine. It is a unique opportunity for the delegates to update their knowledge on such burning issues from learned experts," Maity said.
Among the recent advancements, GlaxoSmithLine Pharmaceuticals, UK, has developed for the first time a falciparum malaria vaccine, which is expected to be marketed in this year only.
In a recent collaborative research by a group of Indian scientists along with Canadian scientists have proved that replacement of the metal antimony of the anti-leishmaniasis drug by arsenic (received from water sources) makes the organisms lismania donovani resistant to drugs.
Moreover, renowned scientists from German Cancer Research Centre (GCRC) will discuss the molecular mechanism of cancer development and on recent breakthroughs in cancer treatment.
Peter Bannasch of GCRC will discuss on fundamental aberrations of carbohydrate metabolism characterizing the initiation and progression of hepatocarcinogenesis.
Hans Jorg Hacker a senior scientist of the same institute will give a deliberation on recent insights into mechanisms of hepatitis B virus infections as a basis for novel therapeutic strategies.
E M Williamson of University of Reading, UK and Prof. Ulrike Holzgrabe, University of Wurzburg, Germany will discuss on Supporting Conventional Therapies with Traditional Herbal Medicine.
Lisa Kathleen Ryan New Jersey Medical School, University of Medicine and Dentistry, New Jersey, USA, will deliver on Beta-Defensins: Antimicrobial Peptides and Immunomodulatory Agents.
Jouni Hirvonen has a topic of discussion on Advanced Nanoformulations for Oral Drug Delivery Applications and many more.Scientists and Professors from BITS, Pillani and Banaras Hindu University, NIPER will also deliver lectures on such issues.
Biswajit Mukherjee, Organizing secretary Pharma Tech IAPST said, "Science and technology has answered many questions related to the insights and queries on various diseases and provided the latest therapeutic approaches to combat them."
Mukherjee said, "This is the time to share information about the advancements as well as the challenges in the discipline and exchange ideas between participants such as academicians, scientists and industrialists and the experts on a timely topic. Our current knowledge will be reviewed by outstanding authorities in the field."